Market Tracker

04/25 4:07am ET

Myriad Genetics Inc (NASDAQ:MYGN)

40.08
Data as of Apr 24
 +0.40 / +1.01%
Today’s Change
20.02
Today|||52-Week Range
42.50
+91.04%
Year-to-Date

Today’s Trading

Previous close39.68
Today’s open39.91
Day’s range-- - --
Volume1,725,685
Average volume (3 months)2,336,351
Market cap$2.8B
Dividend yield--
Data as of 04/24/2014

Growth & Valuation

Earnings growth (last year)+36.15%
Earnings growth (this year)+24.23%
Earnings growth (next 5 years)+14.91%
Revenue growth (last year)+23.62%
P/E ratio17.2
Price/Sales3.55
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc-0.27-1.00%
WXWuXi Pharmatech (Cay...+0.17+0.48%
NPSPNPS Pharmaceuticals ...-0.28-1.08%
MNKDMannkind Corp+0.02+0.31%
Data as of 4:00pm ET, 04/24/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)$0.45
Annual revenue (last year)$613.2M
Annual profit (last year)$147.1M
Net profit margin24.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts